Position in FOLD
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$29,487,988
+$28,942,201 QoQ
Shares Held
2,039,280
+3501.9% QoQ
Ownership
0.649%
of shares outstanding
% of Portfolio
2.07%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in FOLD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026NEXPOINT ASSET MANAGEMENT, L.P. holds $122,388,926 across 5 Biotechnology names. FOLD ranks #3 (24.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TERN |
Terns Pharmaceuticals, Inc.
|
904,200 | $47,669,423 | |
| 2 | ACLX |
Arcellx, Inc.
|
373,150 | $42,845,082 | |
| 3 | FOLD |
AMICUS THERAPEUTICS, INC.
This page
|
2,039,280 | $29,487,988 | |
| 4 | RNA |
Atrium Therapeutics, Inc.
|
150,025 | $2,005,833 | |
| 5 | HRTX |
Heron Therapeutics, Inc. /De/
|
475,750 | $380,600 |
All Filings in FOLD
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $29,487,988 | 2,039,280 | Shares | Other | 2026-05-15 | |
| 2021-06-30 | $545,787 | 56,617 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $559,375 | 56,617 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $1,321,902 | 57,250 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $808,370 | 57,250 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $990,756 | 65,700 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $607,068 | 65,700 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||